<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>responsabilità medica - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/responsabilita-medica/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/responsabilita-medica/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Thu, 18 Jun 2020 09:00:47 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>responsabilità medica - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/responsabilita-medica/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing </title>
		<link>https://www.newpharmaitaly.it/calypso-biotech-completes-caly-002-clinical-batch-manufacturing/</link>
					<comments>https://www.newpharmaitaly.it/calypso-biotech-completes-caly-002-clinical-batch-manufacturing/#respond</comments>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Thu, 18 Jun 2020 09:00:47 +0000</pubDate>
				<category><![CDATA[Immedia press]]></category>
		<category><![CDATA[covid]]></category>
		<category><![CDATA[diritto sanitario]]></category>
		<category><![CDATA[malasanità]]></category>
		<category><![CDATA[ospedali]]></category>
		<category><![CDATA[responsabilità medica]]></category>
		<guid isPermaLink="false">https://www.adnkronos.com/immediapress/salute-e-benessere/2020/06/18/calypso-biotech-completes-caly-clinical-batch-manufacturing_ypPEnqrACTc9N8D1YR9FSP.html</guid>

					<description><![CDATA[<p>AGC Biologics produces humanized monoclonal antibody targeting IL-15 SEATTLE, June 18, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch of CALY-002 for Calypso Biotech. The immunotherapy biotech company retained the services of AGC...</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/calypso-biotech-completes-caly-002-clinical-batch-manufacturing/">Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing </a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.newpharmaitaly.it/calypso-biotech-completes-caly-002-clinical-batch-manufacturing/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
